Tenders of Uk Health Security Agency

Pneumococcal Vaccine For Adults And At Risk Groups (2025)

Management Of Clinical Evaluations, Including Evaluation Initiation, Delivery, Site And Data Management, Monitoring And Analysis Report Writing, In Order To Support Ukhsa's Testing Capabilities. (+1+1 Extension Options)

Clinical Evaluations

The Authority Seeks To Procure An H5 Influenza Vaccine That Includes The Latest Circulating Influenza A (h5n1) Of Avian Origin, A/astrakhan/3212/2020 (h5n8)-like Strain (cber-rg8a) (clade 2.3.4.4b) Which Will Be Held In A Stockpile By The Authority For Use In The Event Of Zoonotic Infections And For Use In Response To The Entry Of H5 Influenza Into The Uk Population.

H5 Influenza Vaccine

The Provision Of Rabies Vaccine For Pre And Post Exposure. The Contracting Authority Estimates Their Requirement Over The Period Of The Contract, Including The Period Of The Optional Extension To Be Up To 62,400 Doses Of Vaccine. Deliveries Will Be Required Over A Period Of 2 Years, With An Option To Extend For Up To An Additional 24 Months. The Opportunity Is Not Split Into Lots As The Requirement Is For A Specific Vaccine.

Money And People System (maps) Programme Design And Delivery Partner

Rabies Vaccine (2025)

The Provision Of Immunoglobulin Products. Deliveries Will Be Required Over A Period Of 2 Years, With An Option To Extend For Up To An Additional 24 Months. Information About Volumes For Each Lot Is Included In The Invitation To Offer Documents.

Request For Information For Viral Load Detection